- Cintas Corp's CTAS price target was raised to $493 from $460 by Goldman Sachs analyst George Tong while maintaining the Buy rating on the shares.
- Tong predicts continued strength from the healthcare sector that is increasingly adopting uniform rental programs at Cintas post-COVID due to cost and hygiene benefits.
- Related: Cintas' Q3 Results Beat Estimates, Clocks 10% Revenue Growth
- The analyst notes the company is well-positioned to handle higher input costs with pricing power and technology-enabled efficiencies.
- Morgan Stanley lowered its price target on CTAS to $389 (a downside of 2.8%) from $416 while maintaining an Equal-Weight rating on the shares.
- Price Action: CTAS shares are trading lower by 0.26% at $400.31 on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
